| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 2.95e-09 | 5 | 100 | 4 | GO:0008294 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.32e-08 | 18 | 100 | 5 | GO:0004016 | |
| GeneOntologyMolecularFunction | cyclase activity | 1.12e-07 | 24 | 100 | 5 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.40e-07 | 25 | 100 | 5 | GO:0016849 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.14e-06 | 118 | 100 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.05e-05 | 230 | 100 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.84e-05 | 38 | 100 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 MYH1 MYH2 MYH8 DNAH10 KIF1A MYO5A KIF1B DHX8 AACS ABCD3 ATP2B1 | 5.72e-05 | 614 | 100 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.11e-04 | 19 | 100 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 5.13e-04 | 7 | 100 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | virus receptor activity | 8.79e-04 | 85 | 100 | 4 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 9.18e-04 | 86 | 100 | 4 | GO:0140272 | |
| GeneOntologyMolecularFunction | actin filament binding | 9.90e-04 | 227 | 100 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.13e-03 | 156 | 100 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.68e-03 | 441 | 100 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8B3 MYH8 DNAH10 KIF1A KIF1B DHX8 RAB36 RHEBL1 ABCD3 ATP2B1 ADSS1 | 1.72e-03 | 775 | 100 | 11 | GO:0017111 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 1.09e-09 | 11 | 100 | 5 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 1.83e-09 | 25 | 100 | 6 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 1.97e-08 | 18 | 100 | 5 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 2.67e-08 | 19 | 100 | 5 | GO:1904321 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 6.79e-08 | 44 | 100 | 6 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 7.60e-08 | 23 | 100 | 5 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 7.80e-08 | 45 | 100 | 6 | GO:0009187 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 5.17e-06 | 334 | 100 | 10 | GO:0030072 | |
| GeneOntologyBiologicalProcess | peptide secretion | 6.53e-06 | 343 | 100 | 10 | GO:0002790 | |
| GeneOntologyBiologicalProcess | insulin secretion | 7.49e-06 | 274 | 100 | 9 | GO:0030073 | |
| GeneOntologyBiologicalProcess | peptide transport | 8.81e-06 | 355 | 100 | 10 | GO:0015833 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 1.11e-05 | 218 | 100 | 8 | GO:0001678 | |
| GeneOntologyBiologicalProcess | positive regulation of metanephric DCT cell differentiation | 2.33e-05 | 2 | 100 | 2 | GO:2000594 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric collecting duct development | 2.33e-05 | 2 | 100 | 2 | GO:1900214 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric collecting duct development | 2.33e-05 | 2 | 100 | 2 | GO:1900215 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric nephron tubule development | 2.33e-05 | 2 | 100 | 2 | GO:1900218 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric nephron tubule development | 2.33e-05 | 2 | 100 | 2 | GO:1900217 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-05 | 2 | 100 | 2 | GO:1901147 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric nephron tubule development | 2.33e-05 | 2 | 100 | 2 | GO:1900205 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric collecting duct development | 2.33e-05 | 2 | 100 | 2 | GO:1900204 | |
| GeneOntologyBiologicalProcess | regulation of metanephric DCT cell differentiation | 2.33e-05 | 2 | 100 | 2 | GO:2000592 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-05 | 2 | 100 | 2 | GO:0072305 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-05 | 2 | 100 | 2 | GO:0072304 | |
| GeneOntologyBiologicalProcess | kidney field specification | 2.33e-05 | 2 | 100 | 2 | GO:0072004 | |
| GeneOntologyBiologicalProcess | pronephric field specification | 2.33e-05 | 2 | 100 | 2 | GO:0039003 | |
| GeneOntologyBiologicalProcess | pattern specification involved in pronephros development | 2.33e-05 | 2 | 100 | 2 | GO:0039017 | |
| GeneOntologyBiologicalProcess | amide transport | 3.73e-05 | 420 | 100 | 10 | GO:0042886 | |
| GeneOntologyBiologicalProcess | hormone secretion | 3.73e-05 | 420 | 100 | 10 | GO:0046879 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 3.94e-05 | 338 | 100 | 9 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 4.03e-05 | 339 | 100 | 9 | GO:0033500 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.05e-05 | 191 | 100 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 4.10e-05 | 130 | 100 | 6 | GO:1901655 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 4.10e-05 | 130 | 100 | 6 | GO:0097306 | |
| GeneOntologyBiologicalProcess | hormone transport | 4.72e-05 | 432 | 100 | 10 | GO:0009914 | |
| GeneOntologyBiologicalProcess | cellular response to glucose stimulus | 4.77e-05 | 196 | 100 | 7 | GO:0071333 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 5.25e-05 | 199 | 100 | 7 | GO:0071331 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 5.60e-05 | 201 | 100 | 7 | GO:0071326 | |
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 6.12e-05 | 277 | 100 | 8 | GO:0090276 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 6.15e-05 | 204 | 100 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | POLR1A MYO5A MYCBP2 PECAM1 CHRM1 SLC1A1 ADCY5 ADCY8 FNDC1 GPR68 EPHA2 KCNJ6 AACS ALOX5 EPHA3 EPHA5 | 6.54e-05 | 1087 | 100 | 16 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 6.94e-05 | 282 | 100 | 8 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 6.94e-05 | 282 | 100 | 8 | GO:0002791 | |
| GeneOntologyBiologicalProcess | metanephric DCT cell differentiation | 6.96e-05 | 3 | 100 | 2 | GO:0072240 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 6.96e-05 | 3 | 100 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | kidney rudiment formation | 6.96e-05 | 3 | 100 | 2 | GO:0072003 | |
| GeneOntologyBiologicalProcess | DCT cell differentiation | 6.96e-05 | 3 | 100 | 2 | GO:0072069 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 7.65e-05 | 286 | 100 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 8.55e-05 | 215 | 100 | 7 | GO:0071322 | |
| GeneOntologyBiologicalProcess | positive regulation of CREB transcription factor activity | 8.56e-05 | 18 | 100 | 3 | GO:0032793 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 1.27e-04 | 53 | 100 | 4 | GO:0021772 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion | 1.34e-04 | 231 | 100 | 7 | GO:0050796 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.39e-04 | 4 | 100 | 2 | GO:0072108 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephros development | 1.39e-04 | 4 | 100 | 2 | GO:1900212 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephros development | 1.39e-04 | 4 | 100 | 2 | GO:1900211 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.39e-04 | 4 | 100 | 2 | GO:1901145 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 1.39e-04 | 4 | 100 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephros development | 1.39e-04 | 4 | 100 | 2 | GO:1900200 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.39e-04 | 4 | 100 | 2 | GO:0072040 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.39e-04 | 4 | 100 | 2 | GO:0072039 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 1.57e-04 | 56 | 100 | 4 | GO:0021988 | |
| GeneOntologyBiologicalProcess | cellular response to gonadotropin stimulus | 1.59e-04 | 22 | 100 | 3 | GO:0071371 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.86e-04 | 171 | 100 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | POLR1A MYO5A MYCBP2 PECAM1 CHRM1 SLC1A1 ADCY5 ADCY8 FNDC1 GPR68 EPHA2 KCNJ6 AACS ALOX5 EPHA3 EPHA5 | 2.30e-04 | 1212 | 100 | 16 | GO:0060341 |
| GeneOntologyBiologicalProcess | metanephric distal convoluted tubule development | 2.31e-04 | 5 | 100 | 2 | GO:0072221 | |
| GeneOntologyBiologicalProcess | metanephric distal tubule development | 2.31e-04 | 5 | 100 | 2 | GO:0072235 | |
| GeneOntologyBiologicalProcess | negative regulation of somatic stem cell population maintenance | 2.31e-04 | 5 | 100 | 2 | GO:1904673 | |
| GeneOntologyBiologicalProcess | distal convoluted tubule development | 2.31e-04 | 5 | 100 | 2 | GO:0072025 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.66e-04 | 343 | 100 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to glucose | 2.76e-04 | 260 | 100 | 7 | GO:0009749 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | MYO5A SLC1A1 ADCY5 ADCY8 CORO1A STXBP3 GPR68 AACS PAX2 PAX6 ATP2B1 EPHA5 XPR1 | 2.80e-04 | 866 | 100 | 13 | GO:0055082 |
| GeneOntologyBiologicalProcess | response to hexose | 3.09e-04 | 265 | 100 | 7 | GO:0009746 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 3.35e-04 | 355 | 100 | 8 | GO:0046883 | |
| GeneOntologyBiologicalProcess | metanephric tubule formation | 3.45e-04 | 6 | 100 | 2 | GO:0072174 | |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 3.45e-04 | 6 | 100 | 2 | GO:1990049 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 3.62e-04 | 272 | 100 | 7 | GO:0034284 | |
| GeneOntologyBiologicalProcess | cell recognition | 4.09e-04 | 198 | 100 | 6 | GO:0008037 | |
| GeneOntologyBiologicalProcess | reflex | 4.50e-04 | 31 | 100 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation involved in kidney development | 4.81e-04 | 7 | 100 | 2 | GO:2000698 | |
| GeneOntologyBiologicalProcess | metanephric collecting duct development | 4.81e-04 | 7 | 100 | 2 | GO:0072205 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 4.81e-04 | 7 | 100 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 4.81e-04 | 7 | 100 | 2 | GO:0072282 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 4.81e-04 | 7 | 100 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 4.81e-04 | 7 | 100 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 4.81e-04 | 7 | 100 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | response to gonadotropin | 4.95e-04 | 32 | 100 | 3 | GO:0034698 | |
| GeneOntologyBiologicalProcess | protein secretion | 5.43e-04 | 480 | 100 | 9 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 5.68e-04 | 483 | 100 | 9 | GO:0035592 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | MYO5A KDM6B CR2 CHRM1 SLC1A1 ADCY1 ADCY5 ADCY6 ADCY8 KLHL22 GPR68 AACS PAX2 PAX6 ATP2B1 EPHA3 EPHA5 | 5.72e-04 | 1450 | 100 | 17 | GO:1901701 |
| GeneOntologyBiologicalProcess | secretory granule localization | 5.93e-04 | 34 | 100 | 3 | GO:0032252 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 6.29e-04 | 490 | 100 | 9 | GO:0071692 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 6.39e-04 | 8 | 100 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | pattern specification involved in kidney development | 6.39e-04 | 8 | 100 | 2 | GO:0061004 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 6.39e-04 | 8 | 100 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 6.39e-04 | 8 | 100 | 2 | GO:1990048 | |
| GeneOntologyBiologicalProcess | renal system pattern specification | 6.39e-04 | 8 | 100 | 2 | GO:0072048 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | 6.61e-04 | 301 | 100 | 7 | GO:0009743 | |
| GeneOntologyBiologicalProcess | pallium development | 7.47e-04 | 222 | 100 | 6 | GO:0021543 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 8.15e-04 | 86 | 100 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | response to alcohol | 8.16e-04 | 312 | 100 | 7 | GO:0097305 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.19e-04 | 9 | 100 | 2 | GO:0003339 | |
| GeneOntologyCellularComponent | muscle myosin complex | 5.52e-05 | 16 | 99 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 1.76e-04 | 59 | 99 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | dendrite | ADCY4 KIF1A MYO5A KIF1B CHRM1 SLC1A1 ADCY8 KCNJ6 ROBO1 ATP2B1 ALOX5 EPHA3 EPHA5 | 2.03e-04 | 858 | 99 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ADCY4 KIF1A MYO5A KIF1B CHRM1 SLC1A1 ADCY8 KCNJ6 ROBO1 ATP2B1 ALOX5 EPHA3 EPHA5 | 2.08e-04 | 860 | 99 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | myosin filament | 2.20e-04 | 25 | 99 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | presynapse | KIF1A MYO5A KIF1B ADGRL1 CHRM1 SLC1A1 ADCY1 ADCY8 ADRA1A STXBP3 KCNJ6 ATP2B1 EPHA3 | 2.77e-04 | 886 | 99 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | axon | KIF1A MYO5A MYCBP2 KIF1B ADGRL1 CRTAC1 CHRM1 SLC1A1 ADCY8 CORO1A KCNJ6 ROBO1 EPHA5 | 2.93e-04 | 891 | 99 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | myosin II complex | 3.10e-04 | 28 | 99 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 8.58e-04 | 155 | 99 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.11e-03 | 43 | 99 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 MYH1 MYH2 MYH8 DNAH10 KIF1A MYO5A PECAM1 KIF1B ODF1 KLHL22 NEK2 CORO1A ADRA1A | 1.30e-03 | 1179 | 99 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL5A1 MYH1 MYH2 MYH8 DNAH10 KIF1A MYO5A PECAM1 KIF1B ODF1 KLHL22 NEK2 CORO1A ADRA1A | 1.39e-03 | 1187 | 99 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | cell body membrane | 1.44e-03 | 47 | 99 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | immunological synapse | 1.62e-03 | 49 | 99 | 3 | GO:0001772 | |
| GeneOntologyCellularComponent | membrane raft | 1.68e-03 | 362 | 99 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.73e-03 | 364 | 99 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY4 KIF1A MYO5A KIF1B CHRM1 SLC1A1 ADCY8 KCNJ6 ROBO1 ATP2B1 CNGA2 ALOX5 EPHA3 EPHA5 | 1.91e-03 | 1228 | 99 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.05e-03 | 277 | 99 | 6 | GO:0042734 | |
| Domain | AC_N | 2.31e-10 | 8 | 101 | 5 | IPR032628 | |
| Domain | Adcy | 2.31e-10 | 8 | 101 | 5 | IPR030672 | |
| Domain | AC_N | 2.31e-10 | 8 | 101 | 5 | PF16214 | |
| Domain | Adcy_conserved_dom | 1.20e-08 | 6 | 101 | 4 | IPR009398 | |
| Domain | DUF1053 | 1.20e-08 | 6 | 101 | 4 | PF06327 | |
| Domain | A/G_cyclase_CS | 2.46e-08 | 17 | 101 | 5 | IPR018297 | |
| Domain | Nucleotide_cyclase | 3.39e-08 | 18 | 101 | 5 | IPR029787 | |
| Domain | - | 3.39e-08 | 18 | 101 | 5 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.58e-08 | 19 | 101 | 5 | PS00452 | |
| Domain | Guanylate_cyc | 4.58e-08 | 19 | 101 | 5 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.58e-08 | 19 | 101 | 5 | PS50125 | |
| Domain | A/G_cyclase | 4.58e-08 | 19 | 101 | 5 | IPR001054 | |
| Domain | CYCc | 4.58e-08 | 19 | 101 | 5 | SM00044 | |
| Domain | PAX | 9.94e-08 | 9 | 101 | 4 | SM00351 | |
| Domain | Paired_dom | 9.94e-08 | 9 | 101 | 4 | IPR001523 | |
| Domain | PAIRED_2 | 9.94e-08 | 9 | 101 | 4 | PS51057 | |
| Domain | PAX | 9.94e-08 | 9 | 101 | 4 | PF00292 | |
| Domain | PAIRED_1 | 9.94e-08 | 9 | 101 | 4 | PS00034 | |
| Domain | Pax2_C | 1.53e-07 | 3 | 101 | 3 | IPR022130 | |
| Domain | Pax2_C | 1.53e-07 | 3 | 101 | 3 | PF12403 | |
| Domain | - | 4.70e-05 | 73 | 101 | 5 | 2.60.120.260 | |
| Domain | Myosin_head_motor_dom | 5.16e-05 | 38 | 101 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.16e-05 | 38 | 101 | 4 | PS51456 | |
| Domain | Myosin_head | 5.16e-05 | 38 | 101 | 4 | PF00063 | |
| Domain | MYSc | 5.16e-05 | 38 | 101 | 4 | SM00242 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.35e-05 | 14 | 101 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.35e-05 | 14 | 101 | 3 | PS00790 | |
| Domain | Eph_TM | 5.35e-05 | 14 | 101 | 3 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.35e-05 | 14 | 101 | 3 | IPR001426 | |
| Domain | EPH_lbd | 5.35e-05 | 14 | 101 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 5.35e-05 | 14 | 101 | 3 | PF01404 | |
| Domain | EphA2_TM | 5.35e-05 | 14 | 101 | 3 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.35e-05 | 14 | 101 | 3 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.35e-05 | 14 | 101 | 3 | IPR001090 | |
| Domain | EPH_LBD | 5.35e-05 | 14 | 101 | 3 | PS51550 | |
| Domain | Myosin_N | 6.66e-05 | 15 | 101 | 3 | PF02736 | |
| Domain | Myosin_N | 6.66e-05 | 15 | 101 | 3 | IPR004009 | |
| Domain | hSH3 | 8.66e-05 | 3 | 101 | 2 | IPR029294 | |
| Domain | hSH3 | 8.66e-05 | 3 | 101 | 2 | PF14603 | |
| Domain | SAM | 1.15e-04 | 88 | 101 | 5 | SM00454 | |
| Domain | Myosin_tail_1 | 1.18e-04 | 18 | 101 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.18e-04 | 18 | 101 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.40e-04 | 19 | 101 | 3 | IPR027401 | |
| Domain | - | 1.40e-04 | 19 | 101 | 3 | 4.10.270.10 | |
| Domain | Galactose-bd-like | 1.57e-04 | 94 | 101 | 5 | IPR008979 | |
| Domain | SAM_DOMAIN | 1.65e-04 | 95 | 101 | 5 | PS50105 | |
| Domain | Kinesin-like_KIF1-typ | 1.73e-04 | 4 | 101 | 2 | IPR022140 | |
| Domain | KIF1B | 1.73e-04 | 4 | 101 | 2 | PF12423 | |
| Domain | SAM | 1.82e-04 | 97 | 101 | 5 | IPR001660 | |
| Domain | fn3 | 2.49e-04 | 162 | 101 | 6 | PF00041 | |
| Domain | - | 2.75e-04 | 106 | 101 | 5 | 1.10.150.50 | |
| Domain | - | 2.86e-04 | 5 | 101 | 2 | 1.10.1200.10 | |
| Domain | PP-binding | 2.86e-04 | 5 | 101 | 2 | PF00550 | |
| Domain | ACP_DOMAIN | 2.86e-04 | 5 | 101 | 2 | PS50075 | |
| Domain | Ephrin_rec_like | 3.24e-04 | 25 | 101 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.24e-04 | 25 | 101 | 3 | IPR011641 | |
| Domain | Kinesin_assoc | 4.28e-04 | 6 | 101 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 4.28e-04 | 6 | 101 | 2 | IPR032405 | |
| Domain | DUF3694 | 4.28e-04 | 6 | 101 | 2 | PF12473 | |
| Domain | PP-bd_ACP | 4.28e-04 | 6 | 101 | 2 | IPR009081 | |
| Domain | Kinesin-like | 4.28e-04 | 6 | 101 | 2 | IPR022164 | |
| Domain | SAM/pointed | 4.34e-04 | 117 | 101 | 5 | IPR013761 | |
| Domain | AMP_BINDING | 4.56e-04 | 28 | 101 | 3 | PS00455 | |
| Domain | SAM_1 | 5.03e-04 | 68 | 101 | 4 | PF00536 | |
| Domain | FN3 | 5.07e-04 | 185 | 101 | 6 | SM00060 | |
| Domain | AMP-binding | 5.60e-04 | 30 | 101 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 5.60e-04 | 30 | 101 | 3 | IPR000873 | |
| Domain | IQ | 5.93e-04 | 71 | 101 | 4 | PF00612 | |
| Domain | Coronin | 5.97e-04 | 7 | 101 | 2 | IPR015505 | |
| Domain | Trimer_CC | 5.97e-04 | 7 | 101 | 2 | IPR015049 | |
| Domain | DUF1899 | 5.97e-04 | 7 | 101 | 2 | IPR015048 | |
| Domain | DUF1899 | 5.97e-04 | 7 | 101 | 2 | SM01166 | |
| Domain | Trimer_CC | 5.97e-04 | 7 | 101 | 2 | PF08954 | |
| Domain | DUF1899 | 5.97e-04 | 7 | 101 | 2 | PF08953 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH8 DNAH10 KIF1A MYO5A KIF1B DHX8 NDST3 RAB36 RHEBL1 ABCD3 ADSS1 | 6.44e-04 | 848 | 101 | 13 | IPR027417 |
| Domain | FN3 | 7.43e-04 | 199 | 101 | 6 | PS50853 | |
| Domain | FN3_dom | 9.58e-04 | 209 | 101 | 6 | IPR003961 | |
| Domain | IQ | 9.74e-04 | 81 | 101 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.44e-03 | 90 | 101 | 4 | IPR000048 | |
| Domain | IQ | 1.63e-03 | 93 | 101 | 4 | PS50096 | |
| Domain | PROTEIN_KINASE_TYR | 1.90e-03 | 97 | 101 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.90e-03 | 97 | 101 | 4 | IPR008266 | |
| Domain | Sushi | 2.80e-03 | 52 | 101 | 3 | PF00084 | |
| Domain | CCP | 3.12e-03 | 54 | 101 | 3 | SM00032 | |
| Domain | Kelch-typ_b-propeller | 3.28e-03 | 55 | 101 | 3 | IPR015915 | |
| Domain | SUSHI | 3.46e-03 | 56 | 101 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.63e-03 | 57 | 101 | 3 | IPR000436 | |
| Domain | Kelch | 3.82e-03 | 58 | 101 | 3 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 4.01e-03 | 59 | 101 | 3 | IPR011043 | |
| Domain | BACK | 4.40e-03 | 61 | 101 | 3 | PF07707 | |
| Domain | BACK | 4.40e-03 | 61 | 101 | 3 | IPR011705 | |
| Domain | Pkinase_Tyr | 5.29e-03 | 129 | 101 | 4 | PF07714 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.20e-09 | 10 | 79 | 5 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.20e-09 | 10 | 79 | 5 | MM14668 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.36e-09 | 14 | 79 | 5 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 9.36e-09 | 14 | 79 | 5 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.09e-08 | 29 | 79 | 6 | M47627 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.40e-08 | 15 | 79 | 5 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.40e-08 | 15 | 79 | 5 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.40e-08 | 15 | 79 | 5 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.02e-08 | 16 | 79 | 5 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.02e-08 | 16 | 79 | 5 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.02e-08 | 16 | 79 | 5 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.02e-08 | 16 | 79 | 5 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 2.85e-08 | 17 | 79 | 5 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.85e-08 | 17 | 79 | 5 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 7.06e-08 | 20 | 79 | 5 | M759 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.32e-07 | 43 | 79 | 6 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.52e-07 | 44 | 79 | 6 | MM15709 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.90e-07 | 24 | 79 | 5 | M47520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.92e-07 | 26 | 79 | 5 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.92e-07 | 26 | 79 | 5 | MM14495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.56e-07 | 27 | 79 | 5 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.56e-07 | 27 | 79 | 5 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 4.32e-07 | 28 | 79 | 5 | M47647 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.20e-07 | 29 | 79 | 5 | M47515 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.37e-07 | 31 | 79 | 5 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 8.70e-07 | 32 | 79 | 5 | M47506 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.01e-06 | 60 | 79 | 6 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.01e-06 | 60 | 79 | 6 | M976 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.02e-06 | 33 | 79 | 5 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 1.02e-06 | 33 | 79 | 5 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.38e-06 | 35 | 79 | 5 | M47969 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.61e-06 | 147 | 79 | 8 | MM15854 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.84e-06 | 37 | 79 | 5 | M749 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.97e-06 | 151 | 79 | 8 | M39329 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.41e-06 | 39 | 79 | 5 | MM14496 | |
| Pathway | KEGG_PURINE_METABOLISM | 2.91e-06 | 159 | 79 | 8 | M14314 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.11e-06 | 41 | 79 | 5 | M512 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 3.96e-06 | 43 | 79 | 5 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 3.96e-06 | 43 | 79 | 5 | M933 | |
| Pathway | REACTOME_GPER1_SIGNALING | 4.98e-06 | 45 | 79 | 5 | M45008 | |
| Pathway | WP_PURINE_METABOLISM | 4.99e-06 | 171 | 79 | 8 | MM15909 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 5.57e-06 | 46 | 79 | 5 | M39828 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 6.90e-06 | 48 | 79 | 5 | M10775 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.03e-05 | 52 | 79 | 5 | M920 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.24e-05 | 54 | 79 | 5 | M26911 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.36e-05 | 55 | 79 | 5 | M39763 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 2.65e-05 | 63 | 79 | 5 | M8 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 3.09e-05 | 65 | 79 | 5 | M15 | |
| Pathway | WP_THERMOGENESIS | 3.10e-05 | 108 | 79 | 6 | M39746 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.43e-05 | 115 | 79 | 6 | M9387 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 4.74e-05 | 71 | 79 | 5 | MM14491 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.13e-05 | 178 | 79 | 7 | M2890 | |
| Pathway | WP_ID_SIGNALING | 9.00e-05 | 16 | 79 | 3 | M39359 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 1.12e-04 | 85 | 79 | 5 | M3578 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.47e-04 | 90 | 79 | 5 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 1.47e-04 | 90 | 79 | 5 | M4013 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.47e-04 | 90 | 79 | 5 | MM15882 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.47e-04 | 90 | 79 | 5 | M835 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.54e-04 | 144 | 79 | 6 | MM14501 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.55e-04 | 91 | 79 | 5 | M39426 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.77e-04 | 211 | 79 | 7 | MM14502 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.90e-04 | 95 | 79 | 5 | M29842 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 2.02e-04 | 52 | 79 | 4 | M5785 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.23e-04 | 219 | 79 | 7 | M29836 | |
| Pathway | KEGG_MELANOGENESIS | 2.53e-04 | 101 | 79 | 5 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.53e-04 | 101 | 79 | 5 | M1979 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.03e-04 | 105 | 79 | 5 | MM15206 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.45e-04 | 108 | 79 | 5 | M17034 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 4.26e-04 | 113 | 79 | 5 | M16817 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 4.26e-04 | 113 | 79 | 5 | M27471 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 5.57e-04 | 29 | 79 | 3 | M27309 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 7.83e-04 | 270 | 79 | 7 | M15514 | |
| Pathway | REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM | 8.49e-04 | 8 | 79 | 2 | M48014 | |
| Pathway | PID_EPHA_FWDPATHWAY | 8.94e-04 | 34 | 79 | 3 | M177 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 9.24e-04 | 134 | 79 | 5 | M29840 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.01e-03 | 205 | 79 | 6 | M752 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.02e-03 | 137 | 79 | 5 | MM15182 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.06e-03 | 36 | 79 | 3 | M39831 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.53e-03 | 150 | 79 | 5 | M27440 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.66e-03 | 42 | 79 | 3 | M791 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.72e-03 | 154 | 79 | 5 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.82e-03 | 156 | 79 | 5 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.87e-03 | 157 | 79 | 5 | M4904 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 1.97e-03 | 12 | 79 | 2 | M27363 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 2.32e-03 | 165 | 79 | 5 | M39400 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.69e-03 | 335 | 79 | 7 | MM14503 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 2.70e-03 | 14 | 79 | 2 | M1473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 2.75e-03 | 50 | 79 | 3 | M47951 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 2.75e-03 | 50 | 79 | 3 | MM15817 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.88e-03 | 252 | 79 | 6 | MM15585 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.91e-03 | 51 | 79 | 3 | M27311 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 2.94e-03 | 106 | 79 | 4 | M42535 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ADCY4 TRHR CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A GPR68 TAS1R2 | 3.16e-03 | 646 | 79 | 10 | MM14962 |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 3.71e-03 | 184 | 79 | 5 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 4.06e-03 | 188 | 79 | 5 | M4844 | |
| Pathway | REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT | 4.48e-03 | 18 | 79 | 2 | M48242 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 4.61e-03 | 60 | 79 | 3 | M40048 | |
| Pubmed | 3.91e-12 | 7 | 101 | 5 | 12613887 | ||
| Pubmed | 2.33e-11 | 9 | 101 | 5 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 2.33e-11 | 9 | 101 | 5 | 17229090 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 4.65e-11 | 10 | 101 | 5 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 4.65e-11 | 10 | 101 | 5 | 8663304 | |
| Pubmed | 4.65e-11 | 10 | 101 | 5 | 16615126 | ||
| Pubmed | 8.51e-11 | 11 | 101 | 5 | 10089566 | ||
| Pubmed | 8.51e-11 | 11 | 101 | 5 | 10808179 | ||
| Pubmed | 1.46e-10 | 12 | 101 | 5 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.66e-10 | 14 | 101 | 5 | 14993377 | |
| Pubmed | 7.96e-10 | 16 | 101 | 5 | 17567809 | ||
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 1.00e-09 | 6 | 101 | 4 | 8126546 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 1.00e-09 | 6 | 101 | 4 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 1.00e-09 | 6 | 101 | 4 | 11549699 | |
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.00e-09 | 6 | 101 | 4 | 8431641 | |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 8.35e-09 | 9 | 101 | 4 | 9417641 | |
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 7883790 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 10197584 | ||
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 8.35e-09 | 9 | 101 | 4 | 7981748 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 2.18e-08 | 11 | 101 | 4 | 35645295 | |
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 11299302 | ||
| Pubmed | PAX immunoreactivity in poorly differentiated small round cell tumors of childhood. | 2.38e-08 | 3 | 101 | 3 | 24897005 | |
| Pubmed | Pax-5 is expressed at the midbrain-hindbrain boundary during mouse development. | 2.38e-08 | 3 | 101 | 3 | 1283313 | |
| Pubmed | Developmental expression of PAM (protein associated with MYC) in the rodent brain. | 2.38e-08 | 3 | 101 | 3 | 12036515 | |
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 8.92e-08 | 15 | 101 | 4 | 1685142 | |
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 8.92e-08 | 15 | 101 | 4 | 2165385 | |
| Pubmed | Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. | 9.49e-08 | 4 | 101 | 3 | 11134340 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 20357587 | ||
| Pubmed | Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. | 9.49e-08 | 4 | 101 | 3 | 8625814 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 11003833 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.37e-07 | 5 | 101 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.37e-07 | 5 | 101 | 3 | 12919077 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 8099544 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 6196357 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 21228062 | ||
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 2.37e-07 | 5 | 101 | 3 | 7959689 | |
| Pubmed | 2.51e-07 | 19 | 101 | 4 | 8575294 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 4.72e-07 | 6 | 101 | 3 | 10077619 | |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 1485966 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 4.72e-07 | 6 | 101 | 3 | 10588881 | |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 12435636 | ||
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 5.69e-07 | 23 | 101 | 4 | 25480914 | |
| Pubmed | Emx2 directs the development of diencephalon in cooperation with Otx2. | 6.81e-07 | 24 | 101 | 4 | 11493561 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 35210422 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 16819597 | ||
| Pubmed | A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. | 8.25e-07 | 7 | 101 | 3 | 7590254 | |
| Pubmed | Characterization of a novel Lbx1 mouse loss of function strain. | 9.53e-07 | 26 | 101 | 4 | 34906895 | |
| Pubmed | Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. | 1.32e-06 | 8 | 101 | 3 | 11704761 | |
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 12297500 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 11403717 | ||
| Pubmed | 1.98e-06 | 31 | 101 | 4 | 12626323 | ||
| Pubmed | Visuomotor anomalies in achiasmatic mice expressing a transfer-defective Vax1 mutant. | 2.26e-06 | 32 | 101 | 4 | 36737666 | |
| Pubmed | 2.81e-06 | 10 | 101 | 3 | 25073978 | ||
| Pubmed | Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle. | 2.81e-06 | 10 | 101 | 3 | 29679560 | |
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 2.81e-06 | 10 | 101 | 3 | 16547242 | |
| Pubmed | Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system. | 2.81e-06 | 10 | 101 | 3 | 22223620 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 2.81e-06 | 10 | 101 | 3 | 17304517 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 2.81e-06 | 10 | 101 | 3 | 8950513 | |
| Pubmed | 3.27e-06 | 35 | 101 | 4 | 26988119 | ||
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 18310078 | ||
| Pubmed | Pax2/5 and Pax6 subdivide the early neural tube into three domains. | 3.86e-06 | 11 | 101 | 3 | 10354469 | |
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 8136524 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 3.86e-06 | 11 | 101 | 3 | 38303699 | |
| Pubmed | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. | 3.86e-06 | 11 | 101 | 3 | 24550361 | |
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 26644518 | ||
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 15517401 | ||
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 5.13e-06 | 12 | 101 | 3 | 19247962 | |
| Pubmed | Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration. | 5.13e-06 | 12 | 101 | 3 | 36070393 | |
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 5.13e-06 | 12 | 101 | 3 | 9611134 | |
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 5.13e-06 | 12 | 101 | 3 | 28600496 | |
| Pubmed | 5.65e-06 | 40 | 101 | 4 | 30898150 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL5A1 POLR1A KIF1A MYO5A MYCBP2 KIF1B ADGRL1 TRRAP SLC1A1 ADCY1 HPS3 DIP2C SERINC5 ATP2B1 CRAMP1 ADSS1 | 6.05e-06 | 1489 | 101 | 16 | 28611215 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 6.66e-06 | 13 | 101 | 3 | 8404542 | |
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 17166926 | ||
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 22880002 | ||
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 8948582 | ||
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 6.66e-06 | 13 | 101 | 3 | 17039519 | |
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 12528186 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 6.89e-06 | 42 | 101 | 4 | 11439183 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26146906 | ||
| Pubmed | Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors. | 8.35e-06 | 2 | 101 | 2 | 25433656 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14635039 | ||
| Pubmed | PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. | 8.35e-06 | 2 | 101 | 2 | 35387670 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 8.35e-06 | 2 | 101 | 2 | 9585413 | |
| Pubmed | Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. | 8.35e-06 | 2 | 101 | 2 | 16914643 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15745964 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31009605 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21934480 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16575183 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7539720 | ||
| Pubmed | Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. | 8.35e-06 | 2 | 101 | 2 | 15843614 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18222416 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19378250 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 8.35e-06 | 2 | 101 | 2 | 22337492 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23328975 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11981823 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8413205 | ||
| Pubmed | PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. | 8.35e-06 | 2 | 101 | 2 | 23194047 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17068292 | ||
| Cytoband | 17p13.1 | 1.40e-04 | 118 | 101 | 4 | 17p13.1 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 5.04e-10 | 10 | 85 | 5 | 53 | |
| GeneFamily | Paired boxes | 5.63e-08 | 9 | 85 | 4 | 675 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.52e-05 | 14 | 85 | 3 | 1095 | |
| GeneFamily | Myosin heavy chains | 4.38e-05 | 15 | 85 | 3 | 1098 | |
| GeneFamily | Sterile alpha motif domain containing | 5.88e-05 | 88 | 85 | 5 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 1.07e-04 | 160 | 85 | 6 | 555 | |
| GeneFamily | WD repeat domain containing|Coronins | 4.52e-04 | 7 | 85 | 2 | 495 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 9.28e-04 | 92 | 85 | 4 | 521 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.44e-03 | 57 | 85 | 3 | 1179 | |
| GeneFamily | DNA polymerases | 5.18e-03 | 23 | 85 | 2 | 535 | |
| GeneFamily | Acyl-CoA synthetase family | 6.60e-03 | 26 | 85 | 2 | 40 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-08 | 158 | 101 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-08 | 158 | 101 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 101 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 101 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 101 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.96e-07 | 118 | 101 | 6 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.96e-07 | 118 | 101 | 6 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 3.11e-07 | 119 | 101 | 6 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-07 | 119 | 101 | 6 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-07 | 119 | 101 | 6 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 3.73e-07 | 200 | 101 | 7 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.95e-07 | 145 | 101 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 164 | 101 | 6 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 171 | 101 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 171 | 101 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 175 | 101 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 182 | 101 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.96e-06 | 184 | 101 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.34e-06 | 187 | 101 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 188 | 101 | 6 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.62e-06 | 189 | 101 | 6 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.76e-06 | 190 | 101 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 192 | 101 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 192 | 101 | 6 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 192 | 101 | 6 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.06e-06 | 192 | 101 | 6 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 5.21e-06 | 193 | 101 | 6 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 194 | 101 | 6 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 194 | 101 | 6 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 194 | 101 | 6 | 16c6fcbd36d473b883fb5361caca86eb134767ab | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.03e-06 | 198 | 101 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 198 | 101 | 6 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 6.21e-06 | 199 | 101 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 6.21e-06 | 199 | 101 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 199 | 101 | 6 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 7.69e-06 | 119 | 101 | 5 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-05 | 130 | 101 | 5 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 63 | 101 | 4 | e1b68ef6123ad084ce602b09fd1ba394785797e5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 63 | 101 | 4 | 9bfd9ba1335a155ed9e56dd41dd3621b37d4234e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 63 | 101 | 4 | 9a90c761898618fc7e5e2984baa1021b74d4ac39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 136 | 101 | 5 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | ASK454-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.94e-05 | 144 | 101 | 5 | 8e693b50bd6c69ce68f44ca6e51f6d0c7f80d82c | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.00e-05 | 145 | 101 | 5 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-05 | 155 | 101 | 5 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 156 | 101 | 5 | 7ccd20e3bbce6a070df45034b0bdc255f267efb1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 160 | 101 | 5 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.21e-05 | 160 | 101 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 160 | 101 | 5 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 162 | 101 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-05 | 165 | 101 | 5 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-05 | 166 | 101 | 5 | 9fa8510adfa3050ee182b4b71e5655abb9bb8a76 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 170 | 101 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-05 | 170 | 101 | 5 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | 3f796d53d3110e5d6e97de53bb49d323944659d6 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | d9fbc2b00dbf9dddc95d9a20d804459a9ebd1820 | |
| ToppCell | facs-GAT-Fat-3m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | e77bfc925d73ccffe3c8cfb13764e70579a7f942 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 172 | 101 | 5 | 0bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.54e-05 | 172 | 101 | 5 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-05 | 174 | 101 | 5 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.92e-05 | 175 | 101 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.92e-05 | 175 | 101 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-05 | 176 | 101 | 5 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 176 | 101 | 5 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.20e-05 | 177 | 101 | 5 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 177 | 101 | 5 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-05 | 178 | 101 | 5 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-05 | 179 | 101 | 5 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-05 | 180 | 101 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-05 | 180 | 101 | 5 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-05 | 181 | 101 | 5 | e7d9910f6143055645b6f03b1018282e6c215f10 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 5.78e-05 | 181 | 101 | 5 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-05 | 181 | 101 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 182 | 101 | 5 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.93e-05 | 182 | 101 | 5 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 182 | 101 | 5 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.09e-05 | 183 | 101 | 5 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 6.25e-05 | 184 | 101 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-05 | 184 | 101 | 5 | 95cf125127658c4c04445c61809d1aed21ee1f83 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-05 | 184 | 101 | 5 | 1e6f86f9e379cd9f453f6b7185f681b44eb63e09 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.25e-05 | 184 | 101 | 5 | a068ae741889d59937690c11e0bf405481402c25 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.25e-05 | 184 | 101 | 5 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.41e-05 | 185 | 101 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-05 | 186 | 101 | 5 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-05 | 186 | 101 | 5 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-05 | 186 | 101 | 5 | b5e094850ac3785775393cd78a939b02339732b0 | |
| ToppCell | (1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.57e-05 | 186 | 101 | 5 | fe0f8e99ca766e004c351835fdbc2dc888dceb62 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.57e-05 | 186 | 101 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 187 | 101 | 5 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | (1)_B_CD27pos|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.74e-05 | 187 | 101 | 5 | bb189942123eb03dd6505f1af8771dd7285bb8b9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.91e-05 | 188 | 101 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.91e-05 | 188 | 101 | 5 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.91e-05 | 188 | 101 | 5 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 188 | 101 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.09e-05 | 189 | 101 | 5 | 473b01c9162b12b90a617c600238436177a0d18d | |
| Drug | dihydroalprenolol | 5.12e-11 | 30 | 101 | 7 | CID000043216 | |
| Drug | dopexamine | 8.41e-11 | 32 | 101 | 7 | CID000055483 | |
| Drug | AC1L1EV8 | 8.61e-11 | 8 | 101 | 5 | CID000002964 | |
| Drug | carvedilol | MYH1 MYH2 ADCY4 MYH8 MYO5A CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A | 1.44e-10 | 161 | 101 | 11 | CID000002585 |
| Drug | ICI 118551 | 1.56e-10 | 57 | 101 | 8 | CID000003682 | |
| Drug | 14,15-dihydroforskolin | 1.93e-10 | 9 | 101 | 5 | CID000194193 | |
| Drug | 6-fluoronorepinephrine | 3.37e-10 | 21 | 101 | 6 | CID000001862 | |
| Drug | 2',5'-dd3'-FSBA | 3.85e-10 | 10 | 101 | 5 | CID003081206 | |
| Drug | NC-5Z | 3.85e-10 | 10 | 101 | 5 | CID003035914 | |
| Drug | benzilate | 5.25e-10 | 66 | 101 | 8 | CID000201538 | |
| Drug | beta-CNA | 6.23e-10 | 23 | 101 | 6 | CID005486190 | |
| Drug | AC1NSKJI | 6.71e-10 | 68 | 101 | 8 | CID005311391 | |
| Drug | AC1L40QM | 7.03e-10 | 11 | 101 | 5 | CID000099213 | |
| Drug | B-Mlvp | 7.03e-10 | 11 | 101 | 5 | CID000195648 | |
| Drug | AC1NY9KD | 7.03e-10 | 11 | 101 | 5 | CID005771741 | |
| Drug | clenbuterol | 7.66e-10 | 142 | 101 | 10 | CID000002783 | |
| Drug | trimetoquinol | 8.27e-10 | 24 | 101 | 6 | CID000005581 | |
| Drug | AC1L8VEV | 8.27e-10 | 24 | 101 | 6 | CID000433433 | |
| Drug | N-ethylmaleimide | MYH1 MYH2 ADCY4 MYH8 KIF1A MYO5A KIF1B CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 STXBP3 POLI POLD3 ATP2B1 | 9.08e-10 | 511 | 101 | 16 | CID000004362 |
| Drug | AC1L1IZ2 | MYH1 MYH2 ADCY4 MYH8 KIF1A MYO5A KIF1B ADCY1 ADCY5 ADCY6 ADCY8 EPHA2 EPHA3 | 9.47e-10 | 304 | 101 | 13 | CID000004795 |
| Drug | 7B-forskolin | 1.40e-09 | 26 | 101 | 6 | CID000130638 | |
| Drug | RU 24926 | 1.80e-09 | 27 | 101 | 6 | CID000122203 | |
| Drug | FCE 23884 | 1.94e-09 | 13 | 101 | 5 | CID000065898 | |
| Drug | AC1L1BJN | 1.94e-09 | 13 | 101 | 5 | CID000001467 | |
| Drug | sclareol glycol | 1.94e-09 | 13 | 101 | 5 | CID000091915 | |
| Drug | nantradol hydrochloride | 1.94e-09 | 13 | 101 | 5 | CID000047652 | |
| Drug | dihydroergocryptine | 2.02e-09 | 49 | 101 | 7 | CID000114948 | |
| Drug | trifluoperazine | MYH1 MYH2 ADCY4 MYH8 MYO5A CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A ATP2B1 ALOX5 | 2.05e-09 | 324 | 101 | 13 | CID000005566 |
| Drug | prenalterol | 2.28e-09 | 28 | 101 | 6 | CID000042396 | |
| Drug | butoxamine | 2.28e-09 | 28 | 101 | 6 | CID000018026 | |
| Drug | AC1Q7BEJ | 2.34e-09 | 50 | 101 | 7 | CID000001224 | |
| Drug | CGP 20712A | 2.70e-09 | 51 | 101 | 7 | CID000002685 | |
| Drug | tolazoline | 2.87e-09 | 29 | 101 | 6 | CID000005504 | |
| Drug | K-Cl | MYH1 MYH2 ADCY4 MYH8 MYO5A AASDH CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A KCNJ6 POLI POLD3 ATP2B1 | 4.02e-09 | 567 | 101 | 16 | CID000004873 |
| Drug | verapamil | MYH1 MYH2 ADCY4 MYH8 MYO5A CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A KCNJ6 ABCD3 ATP2B1 ALOX5 | 4.34e-09 | 490 | 101 | 15 | CID000002520 |
| Drug | zinterol | 4.41e-09 | 31 | 101 | 6 | CID000037989 | |
| Drug | SKF 75670 | 4.51e-09 | 15 | 101 | 5 | CID000173870 | |
| Drug | BMY 42393 | 4.51e-09 | 15 | 101 | 5 | CID000131961 | |
| Drug | AC1L2AAS | 4.51e-09 | 15 | 101 | 5 | CID000068714 | |
| Drug | AC1L1BDQ | ADCY4 CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A GPR68 ALOX5 EPHA3 | 5.23e-09 | 173 | 101 | 10 | CID000001394 |
| Drug | phosphonate analog | 6.59e-09 | 33 | 101 | 6 | CID000475766 | |
| Drug | Depixol | 6.59e-09 | 33 | 101 | 6 | CID000017011 | |
| Drug | iodocyanopindolol | 6.59e-09 | 33 | 101 | 6 | CID000068618 | |
| Drug | San 21009 | 9.22e-09 | 17 | 101 | 5 | CID000152662 | |
| Drug | U754 | 9.22e-09 | 17 | 101 | 5 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 9.22e-09 | 17 | 101 | 5 | CID000084008 | |
| Drug | otenzepad | 9.82e-09 | 61 | 101 | 7 | CID000107867 | |
| Drug | practolol | 1.36e-08 | 37 | 101 | 6 | CID000004883 | |
| Drug | alprenolol | 1.38e-08 | 64 | 101 | 7 | CID000002119 | |
| Drug | S-(-)-Lisuride | 1.54e-08 | 65 | 101 | 7 | CID000003938 | |
| Drug | AC1Q4Y39 | 1.54e-08 | 65 | 101 | 7 | CID000004402 | |
| Drug | 2g6p | 1.61e-08 | 38 | 101 | 6 | CID002740174 | |
| Drug | Ro 41-9067 | 1.72e-08 | 19 | 101 | 5 | CID000125800 | |
| Drug | AC1L3XQA | 1.72e-08 | 19 | 101 | 5 | CID000124009 | |
| Drug | SK&F 82958 | 1.72e-08 | 19 | 101 | 5 | ctd:C071262 | |
| Drug | N6-cyclohexyladenosine | 2.23e-08 | 40 | 101 | 6 | CID000002692 | |
| Drug | Lopac-S-1316 | 2.23e-08 | 40 | 101 | 6 | CID003086457 | |
| Drug | Dvdavp | 2.29e-08 | 20 | 101 | 5 | CID006441676 | |
| Drug | YM435 | 2.29e-08 | 20 | 101 | 5 | CID000132119 | |
| Drug | DAR-0100A | 2.60e-08 | 41 | 101 | 6 | CID000060759 | |
| Drug | mepyramine | 2.88e-08 | 154 | 101 | 9 | CID000004992 | |
| Drug | 4-isopropylaniline | 2.89e-08 | 71 | 101 | 7 | CID000007464 | |
| Drug | methoxamine | 2.89e-08 | 71 | 101 | 7 | CID000006081 | |
| Drug | pyrophosphate | MYH1 MYH2 ADCY4 MYH8 POLR1A MYO5A INPP1 ADCY1 ADCY5 ADCY6 ADCY8 AACS POLI POLD3 ALG1 ADSS1 | 2.97e-08 | 654 | 101 | 16 | CID000001023 |
| Drug | reproterol | 2.99e-08 | 21 | 101 | 5 | CID000025654 | |
| Drug | BRL 37344 | 3.02e-08 | 42 | 101 | 6 | CID000002436 | |
| Drug | CGP 12177 | 3.02e-08 | 42 | 101 | 6 | CID000002687 | |
| Drug | EEDQ | 3.19e-08 | 72 | 101 | 7 | CID000027833 | |
| Drug | i-Pr | 3.51e-08 | 73 | 101 | 7 | CID000448400 | |
| Drug | GSK835726 | 3.86e-08 | 22 | 101 | 5 | CID005311268 | |
| Drug | Scpb | 4.91e-08 | 23 | 101 | 5 | CID000123843 | |
| Drug | methiothepin | 5.11e-08 | 77 | 101 | 7 | CID000004106 | |
| Drug | benzeneacetamide | 5.32e-08 | 46 | 101 | 6 | CID000007680 | |
| Drug | NSC186061 | 5.54e-08 | 118 | 101 | 8 | CID000004163 | |
| Drug | AC1Q7A7H | 6.08e-08 | 47 | 101 | 6 | CID000112184 | |
| Drug | oxymetazoline | 6.11e-08 | 79 | 101 | 7 | CID000004636 | |
| Drug | 3'-phosphate | 6.11e-08 | 79 | 101 | 7 | CID003084658 | |
| Drug | NAIN | 6.18e-08 | 24 | 101 | 5 | CID000195228 | |
| Drug | TL-99 | 6.18e-08 | 24 | 101 | 5 | CID000122132 | |
| Drug | DEPX | 6.18e-08 | 24 | 101 | 5 | CID000001328 | |
| Drug | betaxolol | 6.92e-08 | 48 | 101 | 6 | CID000002369 | |
| Drug | procaterol | 6.92e-08 | 48 | 101 | 6 | CID000004916 | |
| Drug | Neomigran | 6.92e-08 | 48 | 101 | 6 | CID000003066 | |
| Drug | AC1L9NB5 | 7.70e-08 | 25 | 101 | 5 | CID000449609 | |
| Drug | PD 81,723 | 7.70e-08 | 25 | 101 | 5 | CID000122028 | |
| Drug | tiotidine | 7.70e-08 | 25 | 101 | 5 | CID000050287 | |
| Drug | octimibate | 7.70e-08 | 25 | 101 | 5 | CID000065676 | |
| Drug | manganese-ATP | 7.70e-08 | 25 | 101 | 5 | CID000124341 | |
| Drug | N-n-propylnorapomorphine | 7.70e-08 | 25 | 101 | 5 | CID000030137 | |
| Drug | 2 pN | 7.93e-08 | 82 | 101 | 7 | CID000122874 | |
| Drug | eye gene | MYH1 MYH2 ADCY4 MYH8 MYO5A CHRM1 ADCY1 ADCY5 ADCY6 ADCY8 ADRA1A ALOX5 | 8.97e-08 | 369 | 101 | 12 | CID000004782 |
| Drug | metaproterenol | 9.50e-08 | 26 | 101 | 5 | CID000004086 | |
| Drug | racemic timolol | 1.00e-07 | 51 | 101 | 6 | CID000005478 | |
| Drug | SM-10906 | 1.16e-07 | 27 | 101 | 5 | CID006442261 | |
| Drug | mianserin | 1.20e-07 | 87 | 101 | 7 | CID000004184 | |
| Drug | desacetylnantradol | 1.41e-07 | 28 | 101 | 5 | CID000125211 | |
| Drug | tetrahydrofurfuryl alcohol | 1.41e-07 | 28 | 101 | 5 | CID000007360 | |
| Drug | Nocloprostum | 1.41e-07 | 28 | 101 | 5 | CID006435380 | |
| Drug | Revivon | 1.43e-07 | 54 | 101 | 6 | CID000026644 | |
| Drug | LiCl | 1.49e-07 | 134 | 101 | 8 | CID000433294 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 7.42e-06 | 12 | 97 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 7.42e-06 | 12 | 97 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 9.62e-06 | 13 | 97 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | TRHR PECAM1 CRTAC1 ODF1 KDM6B ADCY5 DHX8 FNDC1 FBXL7 CDCA7 KLHL42 PAX2 CORO7 ATP2B1 KLB XPR1 | 1.18e-05 | 1392 | 97 | 16 | EFO_0005763 |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.52e-05 | 15 | 97 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.55e-05 | 261 | 97 | 7 | C0004352 | |
| Disease | congenital nystagmus (is_implicated_in) | 3.20e-05 | 3 | 97 | 2 | DOID:9649 (is_implicated_in) | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.39e-05 | 21 | 97 | 3 | cv:C5680330 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 6.39e-05 | 4 | 97 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.07e-04 | 702 | 97 | 10 | C0009402 | |
| Disease | Large cell carcinoma of lung | 1.59e-04 | 32 | 97 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 1.59e-04 | 32 | 97 | 3 | C0149782 | |
| Disease | waist-hip ratio | THEMIS2 COL5A1 DNAH10 MYCBP2 ADCY5 ADCY8 ADAMTS9 KCNJ6 ROBO1 POLD3 CORO7 L3MBTL3 EPHA3 | 1.88e-04 | 1226 | 97 | 13 | EFO_0004343 |
| Disease | neuroblastoma (is_implicated_in) | 4.73e-04 | 10 | 97 | 2 | DOID:769 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 5.35e-04 | 48 | 97 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 5.69e-04 | 49 | 97 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | nervous system disease (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | FVC change measurement, response to placebo | 8.15e-04 | 13 | 97 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 9.49e-04 | 14 | 97 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | bitter alcoholic beverage consumption measurement | 9.89e-04 | 133 | 97 | 4 | EFO_0010092 | |
| Disease | grip strength measurement | 1.07e-03 | 350 | 97 | 6 | EFO_0006941 | |
| Disease | Hypogammaglobulinemia | 1.41e-03 | 17 | 97 | 2 | C0086438 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.67e-03 | 71 | 97 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | worry measurement | 1.70e-03 | 154 | 97 | 4 | EFO_0009589 | |
| Disease | C-reactive protein measurement | MYH2 CRTAC1 ADCY5 ADCY8 PTPN3 PAX8 KCNJ6 AACS FYB1 L3MBTL3 EPHA3 | 2.03e-03 | 1206 | 97 | 11 | EFO_0004458 |
| Disease | cytotoxicity measurement, response to metformin | 2.16e-03 | 21 | 97 | 2 | EFO_0006952, GO_1901558 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.36e-03 | 80 | 97 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | response to clopidogrel, cardiovascular event measurement | 2.59e-03 | 23 | 97 | 2 | EFO_0006919, GO_1903493 | |
| Disease | Pseudoaphakia | 2.82e-03 | 24 | 97 | 2 | C0524524 | |
| Disease | Lens Opacities | 2.82e-03 | 24 | 97 | 2 | C1510497 | |
| Disease | body weight | POLR1A CRTAC1 ADCY5 ADCY6 CRB1 HHLA2 CORO1A PAX8 PAX2 POLD3 L3MBTL3 | 2.87e-03 | 1261 | 97 | 11 | EFO_0004338 |
| Disease | depressive symptom measurement, response to antidepressant | 3.09e-03 | 88 | 97 | 3 | EFO_0007006, GO_0036276 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRIKILGDCYYCVSG | 456 | P40145 | |
| YYKTGIIRCPDGISI | 231 | Q9BSF8 | |
| VCVITGKGPLREYYS | 316 | Q9BT22 | |
| VGDKIRYSCVTGYIL | 196 | Q7Z407 | |
| LYIVTGRCLVKGYIS | 426 | Q13939 | |
| YVYRCIKSSILLGSI | 421 | Q86V21 | |
| LRIKILGDCYYCVSG | 421 | O43306 | |
| VCGVLYVLRSVYVDD | 321 | O94910 | |
| GLCIISIDRYIGVSY | 116 | P35348 | |
| QYCETGVKEGATLVY | 781 | Q3SY69 | |
| GRTYKELICESYGVR | 136 | Q6PIY5 | |
| DVGACIALVSVRVYY | 216 | P54756 | |
| RIKILGDCYYCVSGL | 316 | Q8NFM4 | |
| LQSLGYTCYSRGVIK | 1036 | Q8NFM4 | |
| IYLTVYCPKDGVNRI | 366 | Q96M93 | |
| FIVVGCYNGLVYVLK | 826 | Q4L235 | |
| TCYGLVIYAGFDTKI | 346 | O60423 | |
| IVYLCGKGDSSIRYF | 281 | P31146 | |
| LRIKILGDCYYCVSG | 511 | O95622 | |
| GYVGDRFKCVTTELY | 971 | Q6W2J9 | |
| LRKIQESYGDVYGIC | 46 | P20020 | |
| ESYGDVYGICTKLKT | 51 | P20020 | |
| NRSLLDKYCVEYGVG | 146 | O95803 | |
| YRKVVILGYRCVGKT | 6 | Q8TAI7 | |
| GEYVITVTGERCVYL | 1316 | P20742 | |
| GCVSKILGRYYETGS | 56 | Q06710 | |
| KCIASAYYRGAQVII | 186 | O95755 | |
| IASAGVAVYRKYICT | 236 | P26045 | |
| SHGCVSKILGRYYET | 61 | Q02548 | |
| YCVLTVAEVCGYRIK | 281 | Q96JM7 | |
| GCVSKILGRYYETGS | 51 | P26367 | |
| GYKSLCVVQGLVDIY | 291 | P49441 | |
| LYTIGTGSYGRCQKI | 11 | P51955 | |
| TTIGYGYRVITDKCP | 151 | P48051 | |
| SYGLVLYEKSICSGG | 451 | Q8NCI6 | |
| CLLYYIKDGITRVGQ | 546 | O60333 | |
| SLASVLEGQKYCYRG | 806 | O15054 | |
| VLAGKGERQLYCYEV | 276 | P57737 | |
| ALCYPRVKVGNEYVT | 401 | P13535 | |
| ALCYPRVKVGNEYVT | 401 | Q9UKX2 | |
| IPEVRIYDSGTYKCT | 96 | P16284 | |
| IYSGCSTGKVVVYDL | 456 | Q8TEB1 | |
| VLCRNEEGKYGYVLR | 746 | O15117 | |
| LLKNGCYGIYITSRV | 1641 | Q5H8C1 | |
| CYGIYITSRVLKASD | 1646 | Q5H8C1 | |
| VSLLDEGIYTCYVGT | 111 | Q9UM44 | |
| EGIYTCYVGTAIQVI | 116 | Q9UM44 | |
| CGGKISDRYYLLAVD | 56 | P50458 | |
| ALCYPRVKVGNEYVT | 401 | P12882 | |
| VTYSYGLGSCVKIES | 186 | Q14990 | |
| SHGCVSKILGRYYET | 61 | Q02962 | |
| YCLELTEAGLKVVGY | 76 | Q9P0R6 | |
| RIKILGDCYYCVSGL | 346 | Q08828 | |
| GYKQRLVSCSEIYTG | 1631 | Q9P2N4 | |
| GTCYTVGGLIERQKY | 856 | Q8N9C0 | |
| DLSVCVVGRYIYAVA | 391 | Q53GT1 | |
| YSCESGYLLVGEKII | 181 | P20023 | |
| TGYLICRYLIDVEGV | 206 | O75319 | |
| QIKYSCTKGYRLIGS | 126 | P17927 | |
| GRVTDVGIRYVAKYC | 361 | Q9UJT9 | |
| VGVVLCNSLRYKIYL | 1796 | Q4ZHG4 | |
| GACVALLSVRVYYKK | 186 | P29317 | |
| SQELYGLICYGELRK | 241 | Q96RY5 | |
| YIEYKTCKDGSVLGV | 496 | Q9Y2E4 | |
| YLVGERTVLAGQCYI | 166 | P11229 | |
| YIRALVDGCATKKGY | 1781 | P20908 | |
| LTVVIYVLIGRFCGY | 556 | P29320 | |
| RYYRCVVSEGLKLGI | 621 | Q86Z14 | |
| ACVDRKGSGRYSIYI | 181 | Q9NQ79 | |
| CLSTIEIGGIYLSYF | 1096 | P82279 | |
| YCKGTQERGYILGSV | 1416 | Q8IVF4 | |
| YLVVTCNYEARKLGV | 86 | Q9UNA4 | |
| VSGKIGLRAVVYYFC | 86 | P43005 | |
| YLAEAGYTSRGKIGC | 601 | Q14562 | |
| CLLYYIKDGITRVGR | 506 | Q12756 | |
| VCGILLYENIYISVG | 96 | Q15743 | |
| VKLVSGRAYYLQLCT | 141 | Q8N9W8 | |
| VKLGTAVKLCYYIDR | 306 | Q9UN30 | |
| YEIYGGETSGKVLTC | 766 | O95602 | |
| IGDVYGVVKAYTTRV | 291 | Q8N142 | |
| YKDAIVISCGYKISR | 171 | P34981 | |
| RIKCGGEKYQLYLSS | 946 | Q969F9 | |
| YIYLSLVGSAGCSEK | 21 | P09917 | |
| LVICRNSKGKYGYVL | 701 | Q5VWT5 | |
| RVYTCEIYPVSATGK | 1471 | O75592 | |
| KRVLIRVTYCGLUSY | 261 | P59797 | |
| TYLDGEGCIVTEKVY | 391 | Q15054 | |
| IGGITYSEVRCAYEV | 536 | O00186 | |
| AKYLATVVGYLVVSR | 321 | P28288 | |
| EGYIYSHCRKVGITL | 606 | P28288 | |
| DGRCATGVLVYLAKY | 336 | Q9BWT1 | |
| CIYYAISKSIGFGVD | 291 | Q16280 | |
| KLCGLGLAYEVYTRG | 266 | Q6J9G0 | |
| ESGICHKYTYGVRAI | 436 | Q9UBH6 | |
| GKYERAIECYTRGIA | 296 | Q9H6T3 | |
| KYGVTTLVRVCDATY | 36 | Q12974 | |
| VLRVCSGVYFEGSIY | 21 | Q5TEJ8 | |
| TCEKLVGYSAVYRVC | 81 | Q86VE9 | |
| QIRYAKLGDTGRYTC | 511 | Q9Y6N7 | |
| GVLLGYEIVDVCYIS | 91 | Q8TE23 | |
| GSQRVYAGICTEYEK | 296 | Q5JVG2 | |
| YTVGYKEGLLSCGIS | 121 | Q96DR4 | |
| YGRLLCSTGEYDKAI | 1026 | Q6PGP7 | |
| LCGSGYLIYFVVKRS | 441 | Q8TDI7 | |
| CLYAAVGKVIYEGLT | 2241 | Q9Y4A5 | |
| ECKGKIYVIGGYTTR | 341 | Q9P2K6 | |
| SKLIYTYCGIVLVAI | 96 | Q9Y4I1 |